newsfilter
← Latest News
GlobeNewswire·

Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic

HOUSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central